MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2018 International Congress

    Clinical predictors of screen-defined dementia in early Parkinson’s

    F. Baig, M. Lawton, M. Rolinski, C. Ruffmann, T. Barber, J. Klein, C. Lo, Y. Ben-Shlomo, M. Hu (Oxford, United Kingdom)

    Objective: Predicting early dementia in Parkinson’s disease (PD) has important implications for individual prognosis, designing clinical trials and targeting novel treatments, but there remains a…
  • 2018 International Congress

    A promising model for cognitive dysfunction in Parkinson’s Disease by AAV-mediated alpha-synuclein overexpression in hippocampus

    E. Cinar, G. Yalcin-Cakmakli, E. Saka, A. Ulusoy, B. Tel, B. Elibol (Ankara, Turkey)

    Objective: Our aim is to model cognitive dysfunction of Parkinson's disease (PD) together with motor deficits by targeted overexpression of alpha-synuclein (a-syn) in bilateral dentate…
  • 2018 International Congress

    Subcortical and Cortical 123I-FP-CIT binding deficits and mild cognitive impairment in Parkinson’s disease

    A. Pilotto, F. Schiano DiCola, E. Premi, V. Garibotto, A. Scalvini, R. Turrone, R. Grasso, B. Bigni, S. Gipponi, B. Paghera, MC. Rizzetti, b. Borroni, A. Padovani (Brescia, Italy)

    Objective: The objective of the study was to evaluate the relationship between basal ganglia and cortical 123I-FP-CIT binding and early cognitive deficits in PD. Background:…
  • 2018 International Congress

    Hypertriglyceridemia is associated with Parkinson disease mild cognitive impairment (PD-MCI)

    S. Ng, KY. Tay, X. Huang, NSY. Chia, S. Archaryya, F. Setiawan, ZH. Lu, J. Tan, YL. Ng, MC. Wen, A. Ng, W. Au, EK. Tan, L. Tan (Singapore, Singapore)

    Objective: Our study aimed to characterise Parkinson disease (PD) mild cognitive impairment (PD-MCI) in early PD and to identify biomarkers associated with PD-MCI. Background: Approximately…
  • 2018 International Congress

    Opposite effects of dopamine on specific NoGo perfomance in young and late onset Parkinson’s disease and the relationship to nigrostriatal degeneration

    D. Kübler, H. Schroll, U. Scheller, R. Buchert, A. Kühn (Berlin, Germany)

    Objective: To investigate inhibitory control under dopamine (DA) in Parkinson’s disease (PD). Background: The pattern of degeneration in PD as well as side effects of…
  • 2018 International Congress

    The Portuguese Version of Montreal Cognitive Assessment as a screening test comparing Vascular Parkinsonism and Parkinson´s Disease in a hospital cross-section study

    A. Velon, M. Mendes, R. Almendra, A. Almeida, M. Correia, C. (Vila Real, Portugal)

    Objective: Compare cognitive function between Vascular Parkinsonism (VaP) and Parkinson´s Disease (PD) patients. Background: Portuguese version of Montreal Cognitive Assessment (MoCA) is a validated screening…
  • 2018 International Congress

    Epidemiological risk factors on cognition with PD patients in male: A cross-sectional study from southwest of China

    Y. Wu, RW. Ou, H. Liu, QQ. Wei, XJ. Gu, Q. Han, LY. Zhang, W. Song, B. Cao, YP. Chen, B. Zhao, HF. Shang (Chengdu, China)

    Objective: To address the effect of the epidemiological risk factors on cognition in male PD patients, taking motor and non-motor clinical features into account. Background:…
  • 2018 International Congress

    Feasibility of a health game on cognition in Parkinson’s disease: Interim analyses of the Parkin’Play Study

    S. vd Weijer, M. Kuijf, A. Duits, R. Kessels, N. de Vries, S. Köhler, G. Tissingh, B. Bloem (Maastricht, Netherlands)

    Objective: The Parkin'Play Study aims to evaluate the feasibility of an individually tailored multi-domain cognitive intervention (a health game) on cognitive performance in Parkinson's Disease…
  • 2018 International Congress

    An investigation of the relationship between computational neuropsychological testing outcomes and symptoms of Parkinson’s disease

    L. Jiang, Y. Zhu, Z. Ye, Z. Pei, L. Chen (Guangzhou, China)

    Objective: The aim of this study was to investigate the relationship between cognition and other symptoms of Parkinson’s disease (PD) using computational neuropsychological tests. Background:…
  • 2018 International Congress

    Diagnostic accuracy and imaging correlates of the Free and Cued Selective Reminding Test for screening mild cognitive impairment in Parkinson’s disease

    J. Pagonabarraga, A. Horta-Barba, J. Marín-Lahoz, S. Martinez-Horta, H. Bejr-Kasem, I. Aracil, J. Pérez-Pérez, B. Pascual-Sedano, J. Kulisevsky (Barcelona, Spain)

    Objective: To assess the diagnostic accuracy of FCSRT for screening mild cognitive impairment in PD (PD-MCI), and to correlate FCSRT scores with gray and white…
  • « Previous Page
  • 1
  • …
  • 1136
  • 1137
  • 1138
  • 1139
  • 1140
  • …
  • 1554
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
    • #25062 (not found)
    • Welcome to the MDS Abstracts Site
    • Effect of marijuana on Essential Tremor: A case report
    • Advanced Search
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley